Allakos Inc - ESG Rating & Company Profile powered by AI
The page includes a questions and answers table on Allakos Inc. Check the bottom of this page for potential risks for Allakos Inc based on sector, geography and size. If you are employed by Allakos Inc and you wish to licence your ESG aseessment, please contact us.
Allakos Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.3; made up of an environmental score of 6.9, social score of 3.0 and governance score of 6.0.
5.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 886 | Veracyte Inc | 5.4 | High |
| 886 | Xlife Sciences AG | 5.4 | High |
| 912 | Allakos Inc | 5.3 | High |
| 912 | Acer Therapeutics Inc | 5.3 | High |
| 912 | Alembic Pharmaceuticals Ltd | 5.3 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Allakos Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Allakos Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Allakos Inc report the average age of the workforce?
Sign up for free to unlockDoes Allakos Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Allakos Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Allakos Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Allakos Inc offer flexible work?
Sign up for free to unlockDoes Allakos Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Allakos Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Allakos Inc conduct supply chain audits?
Sign up for free to unlockDoes Allakos Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Allakos Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Allakos Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Allakos Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Allakos Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Allakos Inc disclose water use targets?
Sign up for free to unlockDoes Allakos Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Allakos Inc have a product recall in the last two years?
Sign up for free to unlockDoes Allakos Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Allakos Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Allakos Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Allakos Inc disclose parental leave metrics?
Sign up for free to unlockDoes Allakos Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Allakos Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Allakos Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Allakos Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Allakos Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Allakos Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Allakos Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Allakos Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Allakos Inc disclose its waste policy?
Sign up for free to unlockDoes Allakos Inc report according to TCFD requirements?
Sign up for free to unlockDoes Allakos Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Allakos Inc disclose energy use targets?
Sign up for free to unlockDoes Allakos Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Allakos Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Allakos Inc
These potential risks are based on the size, segment and geographies of the company.
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical study to atopic dermatitis and chronic spontaneous urticaria. It is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis; and AK006 to treat allergic and inflammatory diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California.